PAK1 and triple-negative breast carcinoma: Accumulation of active PAK1 in the nucleus, cell motility, and cytoskeletal dynamics, and promotes cancer growth and metastasis of triple-negative breast cancer. Increased PAK1 expression in patient biopsies correlated to drug resistance and increased mortality.